ACE2 and COVID-19: We have found significantly higher soluble serum ACE2 levels in highly exposed but uninfected seronegative subjects, either HCW, daily dealing with COVID-19 patients in the hospital or persons cohabiting with infected close relatives, compared to infected seropositive patients.